Congenital heart disease (CHD), the most common congenital malformation, is associated with adverse outcome. Development of fetal echocardiography has made prenatal diagnosis of CHD a reality, and in the process revolutionized its management.
| INTRODUCTION
Congenital heart disease (CHD) is the most prevalent of all fetal malformations, affecting 1% of all births in the United States, 1 and combined with deformations and chromosomal anomalies, and constitutes the leading cause of infant mortality. 2 The more severe the CHD, the worse the outcome. Of 40 000 babies born annually with CHD in the United States, 25% suffer from critical CHD (CCHD), which includes conditions such as ventricular hypoplasia and conotruncal defects. 1 Prenatal detection of these anomalies may optimize management and significantly improve the outcome. Over the decades, this has been the driving force behind the development of fetal echocardiography.
Many investigators have contributed to this progress; however, a comprehensive recognition of all the pioneering work in this field is beyond our scope. In this review, we present a brief historical perspective of the landmark developments in the various modalities of fetal echocardiography and briefly examine its impact on the outcome.
| M-MODE AND TWO-DIMENSIONAL FETAL ECHOCARDIOGRAPHY
The beginnings of echocardiography can be attributed to the pioneering works of a handful of visionaries across several continents. In 1954,
Edler, a cardiologist, and Hertz, a physicist, both at the University of Lund in Norway, were the first to conduct the time-motion or M-mode recordings of heart movements using an ultrasound device called reflectoscope. 3 Subsequent innovations in several countries contributed to the further development of M-mode and two-dimensional echocardiography. [4] [5] [6] [7] The pioneering discovery of the pulmonary valve by M-mode by Nanda and Gramiak group at the University of Rochester in 1972 spurred exponential development of echocardiography in the assessment of CHD including CCHD such as transposition of the great vessels and served as a forerunner of fetal echocardiography. 8, 9 Fetal applications followed but were initially sparse. To the best of our knowledge, in 1964 Wang was the first to report M-mode echocardiography of the fetal heart. 10 A pioneer of echocardiography Figure 2 ) and successfully determined right ventricular cardiac output in six fetuses. In a fetus with premature atrial contractions, a 60% decline was noted in the pulmonary artery time-velocity integral during the ectopic beats. The authors also described flow dynamics in the atria and across the foramen ovale. In a follow-up study, Maulik, Nanda, and coinvestigators further demonstrated the clinical potential of fetal Doppler echocardiography in assessing congenital heart disease. 19 The detected abnormalities included tricuspid regurgitation in a fetus with complete congenital heart block ( Figure 3) , and hemodynamic abnormality associated with tetralogy of Fallot.
Subsequent studies continued to demonstrate the feasibility and diac rhythm, and congenital heart defects. 20 The same year, Silverman, Cardiac structural anomalies were also present in several fetuses.
Duplex Doppler in combination with other echocardiographic modalities were found to be helpful in prognostication. 21 The next year, Reed and colleagues published their experience. Doppler flow velocities were measured across the mitral and tricuspid orifices, and the pulmonary and aortic outflow tracts in normal human fetuses from 18 to 40 weeks of pregnancy. Right and left ventricular outputs were also measured across the tricuspid and mitral orifices and showed right heart dominance. 
| COLOR DOPPLER FETAL ECHOCARDIOGRAPHY
Although duplex pulsed Doppler echocardiography revolutionized noninvasive cardiac assessment, the ability to depict intracardiac flow patterns in real time represented a paradigm shift. 23 The technical As would be expected, the predominant flow is directed away from the transducer toward the distal PA and is characterized by sharp peaks with rapidly accelerating and decelerating slopes. The maximal area under the flow curve for 1 cardiac cycle was measured in kHz-sec (vertical distance between the 2 horizontal arrows = 0.5 kHz), and converted into maximal velocity curve area (s-cm/s) (A) using the instrument calibration factor K = 25.667 cm/s-kHz. Multiplying A by the PA cross-sectional area gave the stroke volume of 3.76 mL. Cardiac output was then calculated by multiplying the stroke volume by the fetal heart rate. Kristoffersen in Norway. 25 Bommer and others also demonstrated duplex Doppler color flow imaging technique using contrast agents. 26 Finally, the autocorrelation technique, developed by Namekawa and colleagues in Japan, allowed real time two-dimensional Doppler flow imaging in the heart. 27 Omoto and associates from this team in Japan pioneered further development and clinical utilization of color Doppler sonography. 28 In the United States, Nanda and colleagues were the first to introduce color flow mapping. As narrated by Omoto, Nanda's laboratory in the University of Alabama in Birmingham purchased two commercially available color Doppler ultrasound devices in 1984,
and Nanda established a preceptorship program which significantly expanded its clinical utilization through research and training. 29, 30 Sahn also made pioneering contribution in this field. to term. 33 The numerous studies since have corroborated, refined, and extended the utilization of fetal color Doppler echocardiography.
| THREE-AND FOUR-DIMENSIONAL FETAL ECHOCARDIOGRAPHY
Introduction of three-dimensional (3D) and four-dimensional (4D) echocardiography, which is 3D imaging in real time, represents a major advance. Development of these systems with the incorporation of Doppler color flow has allowed a more comprehensive assessment of the fetal cardiac structure and circulation than could be achieved with 2D imaging. Two distinct approaches have emerged for 3D imaging.
One is based on 3D image reconstruction out of sequential 2D images.
The other utilized a 2D matrix probe capable of real time true 3D
imaging through capturing and processing a 3D volume image dataset. 
| Reconstructed three-dimensional imaging
The development of 3D echocardiography could be traced to 1970s and 1980s, when pioneering investigators including Dekker and associates, Nanda and colleagues, and others utilized various experimental approaches which essentially consisted of offline reconstruction of 3D images. [34] [35] [36] Subsequent research and development eventually led to the clinical introduction of systems which utilized offline 3D reconstruction from multiplanar 2D images obtained via transthoracic or transesophageal routes by rotational method or parallel scanning. 37 One of the early approaches for reconstructed 3D fetal echocardiography was reported by Nelson and others in San Diego. 38 Utilizing a 2D diagnostic ultrasound device fitted with a positioning sensor, the investigators scanned 15 patients, postprocessed the image data in a workstation, and managed to create a volume dataset out of which they could render images providing structural and functional information, although the quality was suboptimal.
This study showed the feasibility of 3D imaging in fetal echocardiography. There were other initiatives in this field, but a comprehensive review is beyond the scope of this review. The most important innovation in reconstructed 3D fetal cardiac imaging was the introduction of spatiotemporal image correlation or STIC technology, which is an automated process for gating utilizing fetal heart rate allowing generation of 3D image volume dataset from sequential 2D images. 39 Its utility for fetal echocardiography was demonstrated by DeVore, Goncalves, and others. 40, 41 In their preliminary This approach for fetal cardiac imaging has continued to evolve and is widely used in clinical practice. Although STIC-based 3D echocardiography represents a major advance and has been frequently used for fetal applications, it does not represent true real time 3D
imaging and suffers from several limitations including susceptibility to motion artefacts.
| Real time three-dimensional imaging
Similar to the development of the reconstructed approach, the true 3D real time, also known as live/3D echocardiography utilizing twodimensional matrix transducers was initially introduced in adult cardiac patients. [42] [43] [44] A notable technological accomplishment in this field was the development of 2D sparse matrix array technology by von Ramm and associates, incorporating 256 elements. 45 This generated a 3D volume image dataset and subsequent processing allowed true real time 3D imaging. 46 However, this approach was limited because of poor image resolution, and immense computational challenge of processing and rendering 3D dataset. The second-generation matrix array technology overcame these limitations. 47 This system employed 3000 elements for transmission and reception and twostep image data processing, enabling real time image generation and visualization. 46 Nanda was one of the first to explore its clinical potential, and Wang and others from his group published their initial experience in 2003. 
| IMPACT OF FETAL ECHOCARDIOGRAPHY
Any assessment of the impact of fetal echocardiography on CHD should address two main issues: first, the accuracy of the technique in the prenatal detection of CHD, and secondly, the effectiveness of such detection in improving the perinatal outcome. These are further discussed below.
The accuracy of fetal echocardiography as a diagnostic test is influ- There are obvious benefits of prenatal diagnosis of any malfor- 59 Morris and colleagues investigated the effect of proximity of the birth location to a cardiac surgical facility on the survival of neonates with hypoplastic left heart syndrome. 60 These reports highlight that any improvements in the outcome of infants with CCHD may be better achieved when the lesions are recognized prenatally, and managed promptly in appropriate facilities.
| CONCLUSION
The history of fetal echocardiography represents one of the greatest achievements in fetal and perinatal care. Innovations in the diagnostic ultrasound technology have translated over the last few decades into our ability to assess fetal heart and detect cardiac malformations 
